Heat Shock Protein Peptide Complex-96 Vaccination for Newly Diagnosed Glioblastoma: A Phase I, Single-Arm Trial

JCI insight- United States

doi 10.1172/jci.insight.99145

Full Text

Abstract

Available in

Categories

Date

May 17, 2018

Authors

Publisher

American Society for Clinical Investigation

Related search

A Phase 1 Trial of ABT-510 Concurrent With Standard Chemoradiation for Patients With Newly Diagnosed Glioblastoma

Archives of Neurology

English

Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience

Wspolczesna Onkologia

Nuclear Medicine

English

Boron Neutron Capture Therapy for Newly Diagnosed Glioblastoma

Radiotherapy and Oncology

Nuclear Medicine

English

Phase I Clinical Trial of Multiple-Peptide Vaccination for Patients With Advanced Biliary Tract Cancer

Journal of Translational Medicine

Molecular Biology

English

Plasma YKL-40 as a Biomarker for Bevacizumab Efficacy in Patients With Newly Diagnosed Glioblastoma in the Phase 3 Randomized AVAglio Trial

English

Phase II Trial of Temozolomide (TMZ) Plus Irinotecan (CPT-11) in Adults With Newly Diagnosed Glioblastoma Multiforme Before Radiotherapy

Journal of Neuro-Oncology

Cancer Research

English

RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Phase I Clinical Trial of Temsirolimus and Perifosine for Recurrent Glioblastoma

Annals of Clinical and Translational Neurology

English

Cytotoxic Chemotherapeutic Management of Newly Diagnosed Glioblastoma Multiforme

Journal of Neuro-Oncology

Cancer Research

English